Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > Cst Curation Set #15874
Rikova K (2012) CST Curation Set: 15874; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST](PSD)
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Spectrum Download Download

S187-p - AKAP10 (human)
Modsite: SSLAEPVsPsKKHET SwissProt Entrez-Gene
Orthologous residues
AKAP10 (human): S187‑p, AKAP10 (mouse): S187‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S152-p - AKAP2 (human)
Modsite: DsLQVPVsPssTtss SwissProt Entrez-Gene
Orthologous residues
AKAP2 (human): S152‑p, AKAP2 iso4 (human): S383‑p, AKAP2 iso6 (human): S383‑p, AKAP2 (mouse): S152‑p, AKAP2 iso2 (mouse): S152‑p, AKAP2 iso3 (mouse): S152‑p, AKAP2 iso6 (mouse): S193‑p, AKAP2 (rat): S152‑p, AKAP2 (cow): S152‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1029-p - ARHGAP29 (human)
Modsite: VDRLLLAsPPNERNG SwissProt Entrez-Gene
Orthologous residues
ARHGAP29 (human): S1029‑p, ARHGAP29 (mouse): S1039‑p, ARHGAP29 (rat): G1034‑p, ARHGAP29 (cow): S1037‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1187-p - ARHGAP29 (human)
Modsite: EEKPAsPsAAVPPGT SwissProt Entrez-Gene
Orthologous residues
ARHGAP29 (human): S1187‑p, ARHGAP29 (mouse): S1192‑p, ARHGAP29 (rat): S1192‑p, ARHGAP29 (cow): S1195‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1604-p - ARID1A (human)
Modsite: NRtsPsKsPFLHsGM SwissProt Entrez-Gene
Orthologous residues
ARID1A (human): S1604‑p, ARID1A iso2 (human): S1387‑p, ARID1A (mouse): S1605‑p, ARID1A (rat): S1612‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1609-p - ARID1A (human)
Modsite: sKsPFLHsGMkMQKA SwissProt Entrez-Gene
Orthologous residues
ARID1A (human): S1609‑p, ARID1A iso2 (human): S1392‑p, ARID1A (mouse): S1610‑p, ARID1A (rat): S1617‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T666-p - ataxin-2 (human)
Modsite: AtPPVArtsPsGGtW SwissProt Entrez-Gene
Orthologous residues
ataxin‑2 (human): T666‑p, ataxin‑2 iso2 (human): T666‑p, ataxin‑2 (mouse): T635‑p, ataxin‑2 iso2 (mouse): T565‑p, ataxin‑2 (rat): T198‑p, ataxin‑2 (cow): T648‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S667-p - ataxin-2 (human)
Modsite: tPPVArtsPsGGtWs SwissProt Entrez-Gene
Orthologous residues
ataxin‑2 (human): S667‑p, ataxin‑2 iso2 (human): S667‑p, ataxin‑2 (mouse): S636‑p, ataxin‑2 iso2 (mouse): S566‑p, ataxin‑2 (rat): S199‑p, ataxin‑2 (cow): S649‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S289-p - BAG3 (human)
Modsite: RsstPLHsPsPIRVH SwissProt Entrez-Gene
Orthologous residues
BAG3 (human): S289‑p, BAG3 (mouse): C295‑p, BAG3 (rat): C292‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S757-p - BCLAF1 (human)
Modsite: RsSsSsAsPssPssR SwissProt Entrez-Gene
Orthologous residues
BCLAF1 (human): S757‑p, BCLAF1 iso2 (human): S755‑p, BCLAF1 iso3 (human): S755‑p, BCLAF1 iso4 (human): S584‑p, BCLAF1 (mouse): S756‑p, BCLAF1 (rat): S758‑p, BCLAF1 iso3 (rat): S963‑p, BCLAF1 (cow): S758‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S135-p - BMZF-2 (human)
Modsite: GGSRQPssPsHNTNL SwissProt Entrez-Gene
Orthologous residues
BMZF‑2 (human): S135‑p, BMZF‑2 iso2 (human): S138‑p, BMZF‑2 (mouse): S135‑p, BMZF‑2 (rat): S133‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S310-p - CAP1 (human)
Modsite: PKPQtsPsPkRAtKk SwissProt Entrez-Gene
Orthologous residues
CAP1 (human): S310‑p, CAP1 iso2 (human): S309‑p, CAP1 (mouse): S309‑p, CAP1 (rat): S309‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T848-p - CASKIN2 (human)
Modsite: tsPSVtPtPArGtPR SwissProt Entrez-Gene
Orthologous residues
CASKIN2 (human): T848‑p, CASKIN2 iso2 (human): T766‑p, CASKIN2 (mouse): T847‑p, CASKIN2 (rat): T847‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S175-p - CBX1 (human)
Modsite: LTWHsyPsEDDDkkD SwissProt Entrez-Gene
Orthologous residues
CBX1 (human): S175‑p, CBX1 (mouse): S175‑p, CBX1 (rat): S175‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S494-p - CCDC132 (human)
Modsite: KFMEQsRsPsVsPsk SwissProt Entrez-Gene
Orthologous residues
CCDC132 (human): S494‑p, CCDC132 iso3 (human): S464‑p, CCDC132 (mouse): S494‑p, CCDC132 (rat): S54‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S2046-p - CHD-8 (human)
Modsite: QDyEMrVsPsDttPL SwissProt Entrez-Gene
Orthologous residues
CHD‑8 (human): S2046‑p, CHD‑8 iso2 (human): S1767‑p, CHD‑8 (mouse): G2048‑p, CHD‑8 iso2 (mouse): , CHD‑8 (rat): A2046‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S115-p - EHMT2 (human)
Modsite: LLGHATksFPssPsk SwissProt Entrez-Gene
Orthologous residues
EHMT2 (human): S115‑p, EHMT2 iso2 (human): S115‑p, EHMT2 iso4 (human): S172‑p, EHMT2 (mouse): S168‑p, EHMT2 iso4 (mouse): , EHMT2 (rat): S168‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T1020-p - FMNL1 (human)
Modsite: AQEAGADtPGKGEPP SwissProt Entrez-Gene
Orthologous residues
FMNL1 (human): T1020‑p, FMNL1 iso2 (human): T1020‑p, FMNL1 (mouse): T1010‑p, FMNL1 iso2 (mouse): T984‑p, FMNL1 (rat): T954‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1031-p - FMNL1 (human)
Modsite: GEPPAPKsPPKARRP SwissProt Entrez-Gene
Orthologous residues
FMNL1 (human): S1031‑p, FMNL1 iso2 (human): S1031‑p, FMNL1 (mouse): S1021‑p, FMNL1 iso2 (mouse): S995‑p, FMNL1 (rat): S965‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S245-p - GTSE1 (human)
Modsite: KEIPAsPsRTKIPAE SwissProt Entrez-Gene
Orthologous residues
GTSE1 (human): S245‑p, GTSE1 (mouse): Q247‑p, GTSE1 (rat): Q256‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1108-p - HDAC5 (human)
Modsite: AAAAREHsPRPAEEP SwissProt Entrez-Gene
Orthologous residues
HDAC5 (human): S1108‑p, HDAC5 iso2 (human): S1023‑p, HDAC5 iso3 (human): S1109‑p, HDAC5 (mouse): S1099‑p, HDAC5 (rat): S932‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S155-p - HDAC7 (human)
Modsite: FPLRKtVsEPNLkLR SwissProt Entrez-Gene
Orthologous residues
HDAC7 (human): S155‑p, HDAC7 iso3 (human): S155‑p, HDAC7 iso5 (human): S194‑p, HDAC7 iso7 (human): S194‑p, HDAC7 iso8 (human): S211‑p, HDAC7 (mouse): S178‑p, HDAC7 (rat): S156‑p, HDAC7 (cow): S196‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T2701-p - HERC1 (human)
Modsite: LPTRRAQtPPIssLP SwissProt Entrez-Gene
Orthologous residues
HERC1 (human): T2701‑p, HERC1 (mouse): T2699‑p, HERC1 (rat): T2699‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S2705-p - HERC1 (human)
Modsite: RAQtPPIssLPtsPS SwissProt Entrez-Gene
Orthologous residues
HERC1 (human): S2705‑p, HERC1 (mouse): S2703‑p, HERC1 (rat): S2703‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S2706-p - HERC1 (human)
Modsite: AQtPPIssLPtsPSD SwissProt Entrez-Gene
Orthologous residues
HERC1 (human): S2706‑p, HERC1 (mouse): S2704‑p, HERC1 (rat): S2704‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

Y1044-p - IARS (human)
Modsite: IKAPLkPyPVsPsDk SwissProt Entrez-Gene
Orthologous residues
IARS (human): Y1044‑p, IARS (mouse): Y1044‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1047-p - IARS (human)
Modsite: PLkPyPVsPsDkVLI SwissProt Entrez-Gene
Orthologous residues
IARS (human): S1047‑p, IARS (mouse): P1047‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1162-p - IRS2 (human)
Modsite: TttVtPVsPsFAHNP SwissProt Entrez-Gene
Orthologous residues
IRS2 (human): S1162‑p, IRS2 (mouse): S1151‑p, IRS2 (rat): S1154‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T935-p - KIF5B (human)
Modsite: QHPAAsPtHPsAIRG SwissProt Entrez-Gene
Orthologous residues
KIF5B (human): T935‑p, KIF5B (mouse): T935‑p, KIF5B (rat): T935‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

Y37-p - KNOP1 (human)
Modsite: SVLNNDDyFADVsPL SwissProt Entrez-Gene
Orthologous residues
KNOP1 (human): Y37‑p, KNOP1 (mouse): Y46‑p, TSG118 iso2 (mouse): Y46‑p, KNOP1 (rat): Y97‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S608-p - L3MBTL3 (human)
Modsite: sGEMPPAsPsFPRNK SwissProt Entrez-Gene
Orthologous residues
L3MBTL3 (human): S608‑p, L3MBTL3 iso2 (human): S583‑p, L3MBTL3 (mouse): T609‑p, L3MBTL3 (rat): S607‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S540-p - liprin beta 1 (human)
Modsite: KSNKRtAsAPNLAEt SwissProt Entrez-Gene
Orthologous residues
liprin beta 1 (human): S540‑p, liprin beta 1 iso2 (human): S523‑p, liprin beta 1 iso3 (human): S387‑p, liprin beta 1 iso4 (human): S509‑p, liprin beta 1 (mouse): S500‑p, liprin beta 1 iso4 (mouse): S88‑p, liprin beta 1 (rat): S460‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S154-p - MCMBP (human)
Modsite: NANQARVsPStsytP SwissProt Entrez-Gene
Orthologous residues
MCMBP (human): S154‑p, MCMBP iso2 (human): S154‑p, MCMBP (mouse): S154‑p, MCMBP (rat): S154‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S446-p - MEF2D (human)
Modsite: kSEPVsPsRERsPAP SwissProt Entrez-Gene
Orthologous residues
MEF2D (human): S446‑p, MEF2D iso2 (human): S445‑p, MEF2D iso4 (human): S439‑p, MEF2D (mouse): S439‑p, MEF2D iso2 (mouse): S439‑p, MEF2D (rat): S432‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S326-p - MIG-6 (human)
Modsite: VPPREPLsPSNsRTP SwissProt Entrez-Gene
Orthologous residues
MIG‑6 (human): S326‑p, MIG‑6 (mouse): S325‑p, MIG‑6 (rat): S324‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S330-p - MIG-6 (human)
Modsite: EPLsPSNsRTPsPKS SwissProt Entrez-Gene
Orthologous residues
MIG‑6 (human): S330‑p, MIG‑6 (mouse): S329‑p, MIG‑6 (rat): S328‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S125-p - NPM1 (human)
Modsite: AVEEDAEsEDEEEED SwissProt Entrez-Gene
Orthologous residues
NPM1 (human): S125‑p, NPM1 iso2 (human): S125‑p, NPM1 iso3 (human): S125‑p, NPM1 (mouse): S125‑p, NPM1 (rat): S125‑p, NPM1 iso2 (rat): S125‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

Y1853-p - POLR2A (human)
Modsite: ysPssPEytPtsPKy SwissProt Entrez-Gene
Orthologous residues
POLR2A (human): Y1853‑p, POLR2A iso100 (human): Y1853‑p, POLR2A (mouse): Y1853‑p, POLR2A (rat): Y1853‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

Y1909-p - POLR2A (human)
Modsite: ytPtsPKysPtsPty SwissProt Entrez-Gene
Orthologous residues
POLR2A (human): Y1909‑p, POLR2A iso100 (human): Y1909‑p, POLR2A (mouse): Y1909‑p, POLR2A (rat): Y1909‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T1912-p - POLR2A (human)
Modsite: tsPKysPtsPtysPt SwissProt Entrez-Gene
Orthologous residues
POLR2A (human): T1912‑p, POLR2A iso100 (human): T1912‑p, POLR2A (mouse): T1912‑p, POLR2A (rat): T1912‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

Y1923-p - POLR2A (human)
Modsite: ysPtsPKysPtsPty SwissProt Entrez-Gene
Orthologous residues
POLR2A (human): Y1923‑p, POLR2A iso100 (human): Y1923‑p, POLR2A (mouse): Y1923‑p, POLR2A (rat): Y1923‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T714-p - PPFIA3 (human)
Modsite: GPAIPGDtPPPtPRs SwissProt Entrez-Gene
Orthologous residues
PPFIA3 (human): T714‑p, PPFIA3 iso2 (human): T714‑p, PPFIA3 (mouse): T714‑p, PPFIA3 (rat): T712‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T718-p - PPFIA3 (human)
Modsite: PGDtPPPtPRsARLE SwissProt Entrez-Gene
Orthologous residues
PPFIA3 (human): T718‑p, PPFIA3 iso2 (human): T718‑p, PPFIA3 (mouse): T718‑p, PPFIA3 (rat): T716‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S280-p - PPP1R13L (human)
Modsite: DVFARPAsPsLQLLP SwissProt Entrez-Gene
Orthologous residues
PPP1R13L (human): S280‑p, PPP1R13L (mouse): S279‑p, PPP1R13L (rat): S282‑p, PPP1R13L (cow): S278‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1103-p - RAP140 (human)
Modsite: GGNLPPVsPNDsGAK SwissProt Entrez-Gene
Orthologous residues
RAP140 (human): S1103‑p, RAP140 iso2 (human): S666‑p, RAP140 iso3 (human): S1103‑p, RAP140 (mouse): S1059‑p, RAP140 iso2 (mouse): S1089‑p, RAP140 (rat): S1097‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S841-p - RASAL2 (human)
Modsite: FTKRsTQsEDFSRRH SwissProt Entrez-Gene
Orthologous residues
RASAL2 (human): S841‑p, RASAL2 iso2 (human): S982‑p, RASAL2 (mouse): S988‑p, RASAL2 (rat): S639‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1692-p - RBBP6 (human)
Modsite: VGISRNQsHssPsVs SwissProt Entrez-Gene
Orthologous residues
RBBP6 (human): S1692‑p, RBBP6 iso2 (human): S1658‑p, RBBP6 (mouse): S1692‑p, RBBP6 iso2 (mouse): S1658‑p, RBBP6 (rat): S1691‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1695-p - RBBP6 (human)
Modsite: SRNQsHssPsVsPsR SwissProt Entrez-Gene
Orthologous residues
RBBP6 (human): S1695‑p, RBBP6 iso2 (human): S1661‑p, RBBP6 (mouse): S1695‑p, RBBP6 iso2 (mouse): S1661‑p, RBBP6 (rat): S1694‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S487-p - RPRD2 (human)
Modsite: PGtPtsPsNLtsGLK SwissProt Entrez-Gene
Orthologous residues
RPRD2 (human): S487‑p, RPRD2 iso2 (human): S450‑p, RPRD2 iso3 (human): S461‑p, RPRD2 iso5 (human): S461‑p, RPRD2 (mouse): S506‑p, RPRD2 iso2 (mouse): S462‑p, RPRD2 (rat): S377‑p, RPRD2 (cow): S490‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1066-p - SETDB1 (human)
Modsite: RNYGYNPsPVkPEGL SwissProt Entrez-Gene
Orthologous residues
SETDB1 (human): S1066‑p, SETDB1 iso3 (human): S1066‑p, SETDB1 (mouse): , SETDB1 (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T303-p - SF3B1 (human)
Modsite: tPKtERDtPGHGsGW SwissProt Entrez-Gene
Orthologous residues
SF3B1 (human): T303‑p, SF3B1 (mouse): T303‑p, SF3B1 (rat): T303‑p, SF3B1 (cow): T303‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S338-p - SIRT6 (human)
Modsite: PKRERPtsPAPHRPP SwissProt Entrez-Gene
Orthologous residues
SIRT6 (human): S338‑p, SIRT6 iso2 (human): S311‑p, SIRT6 (mouse): S317‑p, SIRT6 (rat): S313‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T78-p - STX7 (human)
Modsite: kEFGsLPttPsEQRQ SwissProt Entrez-Gene
Orthologous residues
STX7 (human): T78‑p, STX7 iso2 (human): T78‑p, STX7 (mouse): T78‑p, STX7 (rat): T78‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S391-p - SUV39H1 (human)
Modsite: GLAGLPGsPKKRVRI SwissProt Entrez-Gene
Orthologous residues
SUV39H1 (human): S391‑p, SUV39H1 (mouse): S391‑p, SUV39H1 (rat): S392‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T86-p - TAX1BP3 (human)
Modsite: QVNGWDMtMVTHDQA SwissProt Entrez-Gene
Orthologous residues
TAX1BP3 (human): T86‑p, TAX1BP3 (mouse): T86‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S203-p - TERF2IP (human)
Modsite: LLGDAPVsPssQkLK SwissProt Entrez-Gene
Orthologous residues
TERF2IP (human): S203‑p, TERF2IP (mouse): S200‑p, TERF2IP (rat): S200‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

T46-p - VGLL4 (human)
Modsite: SALSSHRtGPPPIsP SwissProt Entrez-Gene
Orthologous residues
VGLL4 (human): T46‑p, VGLL4 iso2 (human): T15‑p, VGLL4 iso4 (human): T52‑p, VGLL4 (mouse): T52‑p, VGLL4 (rat): T52‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S52-p - VGLL4 (human)
Modsite: RtGPPPIsPsKRKFs SwissProt Entrez-Gene
Orthologous residues
VGLL4 (human): S52‑p, VGLL4 iso2 (human): S21‑p, VGLL4 iso4 (human): S58‑p, VGLL4 (mouse): S58‑p, VGLL4 (rat): S58‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S1210-p - WDR33 (human)
Modsite: HPPHDGHsPAsRERs SwissProt Entrez-Gene
Orthologous residues
WDR33 (human): S1210‑p, WDR33 iso2 (human): , WDR33 (mouse): S1204‑p, WDR33 (rat): S1205‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S235-p - WIRE (human)
Modsite: PPVKPPPsPVNIRTG SwissProt Entrez-Gene
Orthologous residues
WIRE (human): S235‑p, WIRE iso2 (human): S85‑p, WIRE (mouse): S235‑p, WIRE (rat): S235‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S620-p - ZC3H14 (human)
Modsite: CAYHHPIsPCkAFPN SwissProt Entrez-Gene
Orthologous residues
ZC3H14 (human): S620‑p, ZC3H14 iso2 (human): S620‑p, ZC3H14 iso3 (human): S464‑p, ZC3H14 iso4 (human): S455‑p, ZC3H14 iso5 (human): S595‑p, ZC3H14 iso6 (human): S191‑p, ZC3H14 iso9 (human): S615‑p, ZC3H14 (mouse): S620‑p, ZC3H14 (rat): S620‑p, ZC3H14 (cow): S620‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control

S125-p - ZO1 (human)
Modsite: RPDPEPVsDNEEDsy SwissProt Entrez-Gene
Orthologous residues
ZO1 (human): S125‑p, ZO1 iso2 (human): S125‑p, ZO1 (mouse): S125‑p, ZO1 iso2 (mouse): S125‑p, ZO1 (rat): S113‑p, ZO1 (cow): S100‑p
Characterization
Methods used to characterize site in vivo mass spectrometry
Disease tissue studied:  non-small cell lung cancer, non-small cell squamous cell lung carcinoma
Relevant cell lines - cell types - tissues:  NCI-H1703 (squamous)
Cellular systems studied:  cell lines
Species studied:  human
Comments:  1hr 1uM gleevec, 24hr 1uM gleevec1, 24hr 1uM gleevec2, 3hr 1uM gleevec, 6hr 1uM gleevec, control